Target intelligence / Profile preview

WW domain-containing adapter protein with coiled-coil (WAC)

Target
WAC
Molecular classification
Other (adaptor protein/structural nuclear protein), Nuclear protein, Protein-protein interaction mediator
01

Overview

WW domain-containing adapter protein with coiled-coil (WAC) is a human nuclear protein encoded by the WAC gene and characterized by an internal WW domain and two carboxy-terminal coiled-coil domains[1][3][7]. The WW domain enables WAC to participate in protein-protein interactions, especially with proline-rich linear motifs, and contributes to pathways related to RNA processing, pre-mRNA splicing, and cellular signaling[1][3][7]. The protein has highly conserved regions suggesting additional regulatory functions such as nuclear localization and response to phosphorylation[7]. Loss-of-function mutations in WAC cause DeSanto–Shinawi syndrome, a rare autosomal dominant neurodevelopmental disorder manifesting with facial dysmorphia, cognitive impairment, autism, and ADHD features[7][9]. While WAC is an important structural and functionally pleiotropic nuclear protein, it is not currently considered a direct drug target or therapeutic receptor/enzyme; its primary roles are in basic nuclear protein complexes rather than in extracellular signaling or enzymatic catalysis[1][2][7].

Other names
KIAA1844Wwp4FLJ31290PRO1741BM-016MGC10753DESSHWW domain-containing adapter protein with coiled-coilWW domain-containing adapter with coiled-coilWAC
02

Biological functions

Protein-protein interactions via WW domainRNA processing and pre-mRNA splicingNuclear localization and protein sortingPotential involvement in gene transcription and cell signaling
03

Disease associations

DeSanto–Shinawi syndrome (DESSH)Neurodevelopmental disorders (including autism spectrum disorder and attention deficit hyperactivity disorder)Potential, but not well-established, links to cancer and polycystic kidney disease (from literature MeSH terms; not considered a primary cancer gene)
04

Safety considerations

Not applicable as no drugs or direct therapies target WAC, so no safety concerns established
05

Biomarkers

Germline or somatic mutation/alteration in WAC gene (DESSH diagnosis and genotype-phenotype studies)[7][9]Altered WAC protein localization or expression in experimental models (research fields only)[7]

Beyond the preview

Go deeper on WW domain-containing adapter protein with coiled-coil (WAC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WW domain-containing adapter protein with coiled-coil (WAC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call